CLEDUCATE Stock Overview
Provides education and test preparation training programmes in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
CL Educate Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹96.90 |
| 52 Week High | ₹114.00 |
| 52 Week Low | ₹63.80 |
| Beta | 0.22 |
| 11 Month Change | 8.11% |
| 3 Month Change | 29.11% |
| 1 Year Change | 22.66% |
| 33 Year Change | 170.39% |
| 5 Year Change | 356.00% |
| Change since IPO | -8.17% |
Recent News & Updates
Recent updates
CL Educate Limited's (NSE:CLEDUCATE) Price Is Out Of Tune With Earnings
Aug 09
Returns On Capital Signal Difficult Times Ahead For CL Educate (NSE:CLEDUCATE)
Jun 11CL Educate (NSE:CLEDUCATE) Has Some Difficulty Using Its Capital Effectively
Feb 10Returns On Capital Are Showing Encouraging Signs At CL Educate (NSE:CLEDUCATE)
Oct 19CL Educate (NSE:CLEDUCATE) Has Some Way To Go To Become A Multi-Bagger
Mar 30Returns On Capital Signal Difficult Times Ahead For CL Educate (NSE:CLEDUCATE)
Oct 27Does CL Educate (NSE:CLEDUCATE) Have A Healthy Balance Sheet?
Aug 02CL Educate (NSE:CLEDUCATE) Could Be Struggling To Allocate Capital
Jun 02CL Educate (NSE:CLEDUCATE) Has Debt But No Earnings; Should You Worry?
Feb 07We Think Shareholders May Want To Consider A Review Of CL Educate Limited's (NSE:CLEDUCATE) CEO Compensation Package
Aug 31The Founder & Chairman of CL Educate Limited (NSE:CLEDUCATE), Satya Ramakrishnan, Just Bought A Few More Shares
Mar 21Is CL Educate (NSE:CLEDUCATE) Using Debt In A Risky Way?
Mar 14Should You Buy CL Educate Limited (NSE:CLEDUCATE) For Its Dividend?
Feb 07Insider Buying: The CL Educate Limited (NSE:CLEDUCATE) Founder & Chairman Just Bought ₹70k Worth Of Shares
Dec 19
Health Check: How Prudently Does CL Educate (NSE:CLEDUCATE) Use Debt?
Dec 13Factors Income Investors Should Consider Before Adding CL Educate Limited (NSE:CLEDUCATE) To Their Portfolio
Nov 08Vice Chairman & MD Gautam Puri Just Bought A Handful Of Shares In CL Educate Limited (NSE:CLEDUCATE)
Sep 02Consider This Before Buying CL Educate Limited (NSE:CLEDUCATE) For The 2.6% Dividend
Aug 10Have Insiders Been Buying CL Educate Limited (NSE:CLEDUCATE) Shares?
Jul 07Shareholder Returns
| CLEDUCATE | IN Consumer Services | IN Market | |
|---|---|---|---|
| 7D | 21.0% | 5.9% | 0.4% |
| 1Y | 22.7% | 42.9% | 45.3% |
Return vs Industry: CLEDUCATE underperformed the Indian Consumer Services industry which returned 42.9% over the past year.
Return vs Market: CLEDUCATE underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| CLEDUCATE volatility | |
|---|---|
| CLEDUCATE Average Weekly Movement | 7.1% |
| Consumer Services Industry Average Movement | 6.8% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.4% |
Stable Share Price: CLEDUCATE's share price has been volatile over the past 3 months.
Volatility Over Time: CLEDUCATE's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 354 | Gautam Puri | www.cleducate.com |
CL Educate Limited provides education and test preparation training programmes in India and internationally. It operates in two segments, EdTech and MarTech. The company offers aptitude products for entrance exams, such as CAT, XAT, SNAP, CLAT, AILET, etc.; knowledge products for entrance exams, including JEE, NEET, GATE, and CUET; and international education products for international exams, such as GRE, GMAT, SAT, TOEFL, and IELTS under the Career Launcher brand.
CL Educate Limited Fundamentals Summary
| CLEDUCATE fundamental statistics | |
|---|---|
| Market cap | ₹5.09b |
| Earnings (TTM) | ₹137.48m |
| Revenue (TTM) | ₹3.23b |
37.9x
P/E Ratio1.6x
P/S RatioIs CLEDUCATE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLEDUCATE income statement (TTM) | |
|---|---|
| Revenue | ₹3.23b |
| Cost of Revenue | ₹2.36b |
| Gross Profit | ₹861.96m |
| Other Expenses | ₹724.48m |
| Earnings | ₹137.48m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.56 |
| Gross Margin | 26.73% |
| Net Profit Margin | 4.26% |
| Debt/Equity Ratio | 11.5% |
How did CLEDUCATE perform over the long term?
See historical performance and comparison